Q3 2023 EPS Estimates for Atara Biotherapeutics, Inc Raised by HC Wainwright (NASDAQ:ATRA) modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.
Atara Biotherapeutics, Inc (NASDAQ:ATRA) Sees Significant Growth in Short Interest kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
31.07.2023 - Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today .
Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Free Report) was the recipient of a large decrease in short interest during the month of June. As of June 30th, there was short interest totalling 11,700,000 shares, a decrease of 11.4% from the June 15th total of 13,200,000 shares. Based on an average daily volume of 1,940,000 shares, […]